Vanguard Group Inc 10x Genomics, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,118,086 shares of TXG stock, worth $99.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,118,086
Previous 10,933,549
1.69%
Holding current value
$99.3 Million
Previous $157 Million
38.18%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding TXG
# of Institutions
303Shares Held
109MCall Options Held
228KPut Options Held
157K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.8MShares$115 Million1.21% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL7.1MShares$63.4 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$57.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.38MShares$48 Million0.03% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.36MShares$47.9 Million0.03% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $849M
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...